Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GRM4 | Q14833 | 7/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | GRM6 | O15303 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | GRM8 | O00222 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 5/20 | 0.32 |
| ▸ | GRM5 | P41594 | 4/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.32 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL160641 | 0.85 | THRB (0.35) | CYP2C9THRBPOLBALDH1A1MEN1 | |
| SCHEMBL31065065 | 0.83 | THRB (0.34) | CYP2C9THRBPOLBALDH1A1MEN1 | |
| SCHEMBL31065066 | 0.83 | THRB (0.34) | CYP2C9THRBPOLBALDH1A1MEN1 | |
| SCHEMBL22092713 | 0.73 | L3MBTL1 (0.36) | ALDH1A1MEN1KMT2APKMLMNA | |
| SCHEMBL1072980 | 0.70 | ALDH1A1 (0.36) | CYP2C9THRBPOLBALDH1A1PKM | |
| SCHEMBL471870 | 0.69 | — | — | |
| SCHEMBL905260 | 0.68 | THRB (0.42) | CYP2C9THRBPOLBGRM4ALDH1A1 | |
| SCHEMBL12517650 | 0.67 | GRM4 (0.34) | CYP2C9THRBGRM4ALDH1A1GRM6 | |
| SCHEMBL866125 | 0.67 | GRIN2D (0.53) | CYP2C9THRBPOLBPKMSLC22A2 | |
| Hydrochloric Acid SCHEMBL11330577 | 0.65 | THRB (0.40) | CYP2C9THRBPOLBALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10478512-B2 | Charge-balanced imaging agents | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2019-11-19 | — | — | US | disclosed |
| US-10201621-B2 | Charge-balanced imaging agents | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2019-02-12 | — | — | US | disclosed |
| US-20180177896-A1 | CHARGE-BALANCED IMAGING AGENTS | BETH ISRAEL DEACONESS MEDICAL CT INC (US) | 2018-06-28 | — | — | US | disclosed |
| EP-2393420-B1 | CHARGE-BALANCED IMAGING AGENTS | BETH ISRAEL DEACONESS MEDICAL CT INC (US) | 2018-05-30 | — | — | EP | disclosed |
| US-20170290927-A1 | CHARGE-BALANCED IMAGING AGENTS | BETH ISRAEL DEACONESS MEDICAL CT INC (US) | 2017-10-12 | — | — | US | disclosed |
| US-20170290928-A1 | USE OF CHARGE-BALANCED IMAGING AGENTS FOR DETERMINING RENAL FUNCTION | BETH ISRAEL DEACONESS MEDICAL CT INC (US) | 2017-10-12 | — | — | US | disclosed |
| US-9687567-B2 | Charged-balanced imaging agents | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| US-20150209451-A1 | CHARGED-BALANCED IMAGING AGENTS | BETH ISRAEL HOSPITAL (US) | 2015-07-30 | — | — | US | disclosed |
| US-9023611-B2 | Charged-balanced imaging agents | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2015-05-05 | — | — | US | disclosed |
| US-20120028291-A1 | CHARGED-BALANCED IMAGING AGENTS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2012-02-02 | — | — | US | disclosed |
| EP-2393420-A1 | CHARGE-BALANCED IMAGING AGENTS | Beth Israel Deaconess Medical Center, Inc. (US) | 2011-12-14 | — | — | EP | disclosed |
| WO-2010091243-A1 | CHARGE-BALANCED IMAGING AGENTS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2010-08-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10201621-B2 | Charge-balanced imaging agents | PHOSPHO1, ACTB, CYTH3 | CYP2C9 4880/4885THRB 1779/4885POLB 3210/4885 |
| US-10478512-B2 | Charge-balanced imaging agents | PHOSPHO1, ACTB, CYTH3 | CYP2C9 4880/4885THRB 1779/4885POLB 3210/4885 |
| US-20170290928-A1 | USE OF CHARGE-BALANCED IMAGING AGENTS FOR DETERMINING RENAL FUNCTION | ATP6V1B1, SLC8B1, PHOSPHO1 | CYP2C9 4862/4885THRB 2285/4885POLB 2589/4885 |
| US-20150209451-A1 | CHARGED-BALANCED IMAGING AGENTS | PHOSPHO1, ACTB, ARFGAP1 | CYP2C9 4880/4885THRB 1581/4885POLB 3018/4885 |
| US-20120028291-A1 | CHARGED-BALANCED IMAGING AGENTS | PHOSPHO1, ACTB, ARFGAP1 | CYP2C9 4880/4885THRB 1581/4885POLB 3018/4885 |
| US-20170290927-A1 | CHARGE-BALANCED IMAGING AGENTS | PHOSPHO1, ACTB, CYTH3 | CYP2C9 4880/4885THRB 1779/4885POLB 3210/4885 |
| US-20180177896-A1 | CHARGE-BALANCED IMAGING AGENTS | PHOSPHO1, ACTB, CYTH3 | CYP2C9 4880/4885THRB 1779/4885POLB 3210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.